Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome

References

• Aguirre L, Arias N, Macarulla MT, et al. 2011. Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J. 4:189–198.
   Google Scholar
• Bahceci M, Aydemir M, Tuzcu A. 2007. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome. Fertil Steril. 87:1363–1368.
   PubMed Web of Science ®Google Scholar
• Baillargeon JP, Iuorno MJ, Nestler JE. 2003. Insulin sensitizers for polycystic ovary syndrome. Clin Obstet Gynecol. 46:325–340.
   PubMed Web of Science ®Google Scholar
• Barber TM, Bennett AJ, Groves CJ, et al. 2008. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia 51:1153–1158.
   PubMed Web of Science ®Google Scholar
• Bogovich K, Richards JS. 1982. Androgen biosynthesis in developing ovarian follicles: evidence that luteinizing hormone regulates thecal 17 alpha-hydroxylase and C17-20-lyase activities. Endocrinology 111:1201–1208.
   PubMed Web of Science ®Google Scholar
• Carvalho CR, Carvalheira JB, Lima MH, et al. 2003. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways. Endocrinology 144:638–647.
   PubMed Web of Science ®Google Scholar
• Doi SA, Al-Zaid M, Towers PA, et al. 2005. Irregular cycles and steroid hormones in polycystic ovary syndrome. Hum Reprod. 20:2402–2408.
   PubMed Web of Science ®Google Scholar
• Duez H, Lamarche B, Valéro R, et al. 2008. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation 117:2369–2376.
   PubMed Web of Science ®Google Scholar
• Franks S, Mason H, Willis D. 2000. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol. 25:49–52.
   Web of Science ®Google Scholar
• Fukuda S, Orisaka M, Tajima K, et al. 2009. Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP kinase in bovine theca cells. J Ovarian Res. 2:17–24.
   PubMed Web of Science ®Google Scholar
• Hollman PC, De Vries JH, van Leeuwen SD, et al. 1995. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr. 62:1276–1282.
   PubMed Web of Science ®Google Scholar
• Honnma H, Endo T, Henmi H, et al. 2006. Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Apoptosis 11:1525–1533.
   PubMed Web of Science ®Google Scholar
• Juywiak S, Wójcicki J, Mokrzycki K, et al. 2005. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits. Pharmacol Rep. 57:604–609.
   PubMed Web of Science ®Google Scholar
• Kafali H, Iriadam M, Ozardali I, et al. 2004. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res. 35:103–108.
   PubMed Web of Science ®Google Scholar
• Krishna PS, Vani K, Prasad MR, et al. 2013. In silico molecular docking analysis of prodigiosin and cycloprodigiosin as COX-2 inhibitors. Springerplus 2:172–179.
   PubMed Web of Science ®Google Scholar
• Lansdown A, Rees DA. 2012. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target ? Clin Endocrinol (Oxf). 77:791–801.
   PubMed Web of Science ®Google Scholar
• Li M, Youngren JF, Dunaif A, et al. 2002. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab. 87:4088–4093.
   PubMed Web of Science ®Google Scholar
• Linares R, Hernandez D, Moran C, et al. 2013. Unilateral or bilateral vagotomy induces ovulation in both ovaries of rats with polycystic ovarian syndrome. Reprod Biol Endocrinol. 11:68–77.
   PubMed Web of Science ®Google Scholar
• Mendonca HC, Montenegro RM, Foss MC, et al. 2004. Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome. Braz J Med Biol Res. 37:729–736.
   PubMed Web of Science ®Google Scholar
• Moghetti P, Castello R, Negri C, et al. 2000. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 85:139–146.
   PubMed Web of Science ®Google Scholar
• Munir I, Yen H, Geller DH, et al. 2004. Insulin augmentation of 17a-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology 145:175–183.
   PubMed Web of Science ®Google Scholar
• Musso C, Shawker T, Cochran E, et al. 2005. Clinical evidence that hyperinsulinaemia independent of gonadotropins stimulates ovarian growth. Clin Endocrinol (Oxf). 63:73–78.
   PubMed Web of Science ®Google Scholar
• Ota H, Fukushima M, Maki M. 1983. Endocrinological and histological aspects of the process of polycystic ovary formation in the rat treated with testosterone propionate. Tohoku J Exp Med. 140:121–131.
   PubMed Web of Science ®Google Scholar
• Shah KN, Patel SS. 2014. Phosphatidylinositide 3-kinase: a newer molecular target in metabolic and hormonal pathway of polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 122:261–267.
   PubMed Web of Science ®Google Scholar
• Vandermolen DT, Ratts VS, Evans WS, et al. 2001. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril. 75:310–315.
   PubMed Web of Science ®Google Scholar
• Walker EH, Pacold ME, Perisic O, et al. 2000. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell. 6:909–919.
   PubMed Web of Science ®Google Scholar
• Wang F, Yu B, Yang W, et al. 2012. Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. J Ovarian Res. 5:15–21.
   PubMed Web of Science ®Google Scholar
• Wickenheisser JK, Nelson-Degrave VL, McAllister JM. 2005. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab. 90:1720–1727.
   PubMed Web of Science ®Google Scholar
• Yaba A, Demir N. 2012. The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS). J Ovarian Res. 5:38–50.
   PubMed Web of Science ®Google Scholar
• Zhai HL, Wu H, Xu H, et al. 2012. Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats. Reprod Biol Endocrinol. 10:5–13.
   PubMed Web of Science ®Google Scholar